Shridhara Alva1, Timothy Bailey2, Ronald Brazg3, Erwin S Budiman1, Kristin Castorino4, Mark P Christiansen5, Gregory Forlenza6, Mark Kipnes7, David R Liljenquist8, Hanqing Liu1. 1. Abbott Diabetes Care, Alameda, CA, USA. 2. AMCR Institute, Escondido, CA, USA. 3. Rainier Clinical Research Center, Renton, WA, USA. 4. Sansum Diabetes Research Institute, Santa Barbara, CA, USA. 5. Diablo Clinical Research, Walnut Creek, CA, USA. 6. Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO, USA. 7. DGD Clinic, San Antonio, TX, USA. 8. Rocky Mountain Diabetes Center, Idaho Falls, ID, USA.
Abstract
BACKGROUND: In this study, we evaluated the analytical performance of the second-generation factory-calibrated FreeStyle Libre Flash Glucose Monitoring (FreeStyle Libre 2) System compared to plasma venous blood glucose reference, Yellow Springs Instrument 2300 (YSI). METHODS: The study enrolled participants aged four and above with type 1 or type 2 diabetes at seven sites in the United States. Adult participants (18+ years) participated in three in-clinic sessions and pediatric participants (4-17 years) participated in up to two in-clinic sessions stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13, or 14 of sensor wear. Participants aged 11+ underwent supervised glycemic manipulation during in-clinic sessions to achieve glucose levels across the measurement range of the System. Performance evaluation included accuracy measures such as the proportion of continuous glucose monitoring (CGM) values that were within ±20% or ±20 mg/dL of reference glucose values, and bias measures such as the mean absolute relative difference (MARD) between CGM and reference values. RESULTS: Data from the 144 adults and 129 pediatric participants were analyzed. Percent of sensor results within ±20%/20 mg/dL of YSI reference were 93.2% and 92.1%, and MARD was 9.2% and 9.7% for the adults and pediatric participants, respectively. The System performed well in the hypoglycemic range, with 94.3% of the results for the adult population and 96.1% of the data for pediatric population being within 15 mg/dL of the YSI reference. The time lag was 2.4 ± 4.6 minutes for adults and 2.1 ± 5.0 minutes for pediatrics. CONCLUSIONS: The System demonstrated improved analytical accuracy performance across the dynamic range during the 14-day sensor wear period as compared to the previous-generation device.NCT#: NCT03607448 and NCT03820050.
BACKGROUND: In this study, we evaluated the analytical performance of the second-generation factory-calibrated FreeStyle Libre Flash Glucose Monitoring (FreeStyle Libre 2) System compared to plasma venous blood glucose reference, Yellow Springs Instrument 2300 (YSI). METHODS: The study enrolled participants aged four and above with type 1 or type 2 diabetes at seven sites in the United States. Adult participants (18+ years) participated in three in-clinic sessions and pediatric participants (4-17 years) participated in up to two in-clinic sessions stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13, or 14 of sensor wear. Participants aged 11+ underwent supervised glycemic manipulation during in-clinic sessions to achieve glucose levels across the measurement range of the System. Performance evaluation included accuracy measures such as the proportion of continuous glucose monitoring (CGM) values that were within ±20% or ±20 mg/dL of reference glucose values, and bias measures such as the mean absolute relative difference (MARD) between CGM and reference values. RESULTS: Data from the 144 adults and 129 pediatric participants were analyzed. Percent of sensor results within ±20%/20 mg/dL of YSI reference were 93.2% and 92.1%, and MARD was 9.2% and 9.7% for the adults and pediatric participants, respectively. The System performed well in the hypoglycemic range, with 94.3% of the results for the adult population and 96.1% of the data for pediatric population being within 15 mg/dL of the YSI reference. The time lag was 2.4 ± 4.6 minutes for adults and 2.1 ± 5.0 minutes for pediatrics. CONCLUSIONS: The System demonstrated improved analytical accuracy performance across the dynamic range during the 14-day sensor wear period as compared to the previous-generation device.NCT#: NCT03607448 and NCT03820050.
Authors: Kellee M Miller; Julia Hermann; Nicole Foster; Sabine E Hofer; Michael R Rickels; Thomas Danne; Mark A Clements; Eggert Lilienthal; David M Maahs; Reinhard W Holl Journal: Diabetes Care Date: 2019-10-31 Impact factor: 19.112
Authors: Yogish C Kudva; Andrew J Ahmann; Richard M Bergenstal; James R Gavin; Davida F Kruger; L Kurt Midyett; Eden Miller; Dennis R Harris Journal: J Endocr Soc Date: 2018-11-14
Authors: Daniel A Hochfellner; Amra Simic; Marlene T Taucher; Lea S Sailer; Julia Kopanz; Tina Pöttler; Julia K Mader Journal: Biosensors (Basel) Date: 2022-02-09
Authors: Rodolfo J Galindo; Guillermo E Umpierrez; Robert J Rushakoff; Ananda Basu; Suzanne Lohnes; James H Nichols; Elias K Spanakis; Juan Espinoza; Nadine E Palermo; Dessa Garnett Awadjie; Leigh Bak; Bruce Buckingham; Curtiss B Cook; Guido Freckmann; Lutz Heinemann; Roman Hovorka; Nestoras Mathioudakis; Tonya Newman; David N O'Neal; Michaela Rickert; David B Sacks; Jane Jeffrie Seley; Amisha Wallia; Trisha Shang; Jennifer Y Zhang; Julia Han; David C Klonoff Journal: J Diabetes Sci Technol Date: 2020-09-28
Authors: Nancy Elbarbary; Othmar Moser; Saif Al Yaarubi; Hussain Alsaffar; Adnan Al Shaikh; Ramzi A Ajjan; Asma Deeb Journal: Diab Vasc Dis Res Date: 2021 Nov-Dec Impact factor: 3.291
Authors: Sara Styles; Ben Wheeler; Alisa Boucsein; Hamish Crocket; Michel de Lange; Dana Signal; Esko Wiltshire; Vicki Cunningham; Anita Lala; Wayne Cutfield; Martin de Bock; Anna Serlachius; Craig Jefferies Journal: J Diabetes Metab Disord Date: 2021-10-05
Authors: Trisha Shang; Jennifer Y Zhang; Andreas Thomas; Mark A Arnold; Beatrice N Vetter; Lutz Heinemann; David C Klonoff Journal: J Diabetes Sci Technol Date: 2021-06-13
Authors: Ana Díez-Fernández; María Dolores Rodríguez-Huerta; Rubén Mirón-González; José Alberto Laredo-Aguilera; Noelia María Martín-Espinosa Journal: Int J Environ Res Public Health Date: 2021-03-18 Impact factor: 3.390